A recent study shows that 57.5% of commercially insured patients had at least one chronic condition in 2024, with significant health implications and costs.

The metered dose inhalers market is set to grow significantly, reaching $18.4 billion by 2034 due to increasing respiratory conditions worldwide.

The global patient monitoring devices market is anticipated to reach USD 118.21 billion by 2033, growing at a CAGR of 10.21% fueled by aging populations and ongoing technological advancements.

DarioHealth recently shared an update to its shareholders, emphasizing strategic progress, growth opportunities, and market demand for value-based care solutions.

The digital therapeutics market is forecasted to grow at a CAGR of 26.3% from 2025 to 2032, driven by increasing chronic diseases and the need for scalable health solutions.

Explore how local health initiatives are effectively addressing chronic diseases across the U.S., enhancing health outcomes and controlling costs.

A recent study reveals a troubling rise of chronic conditions in the U.S. workforce, with a decrease in disability claims. What does this mean for employers?

The pressure monitoring market is projected to reach $25.48 billion by 2032, driven by technological advancements and rising chronic conditions worldwide.

DarioHealth has secured a major partnership with a prominent U.S. healthcare institution, expecting to enhance revenue and support chronic condition management through its digital health solutions.